• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妊娠毒血症中羊水升压成分的鉴定

Identification of vasopressor constituents of amniotic fluid in pregnancy toxaemia.

作者信息

Dhall K, Kumar M, Dhall G I, Jain P, Singh K T, Chakravorti R N

出版信息

Ric Clin Lab. 1979 Jan-Mar;9(1):25-33. doi: 10.1007/BF02905024.

DOI:10.1007/BF02905024
PMID:493811
Abstract

The vasopressor activity of human amniotic fluid was assessed in 46 primigravidas during the third trimester of pregnancy. The subjects included 20 normal and 26 cases of pregnancy toxaemia. For identification of the vasopressor activity of the amniotic fluid, blood pressure measurements were made in the intact rat, and the smooth muscle contraction of the rat ascending colon preparation was determined in vitro. The samples of amniotic fluid showing vasopressor activity were lyophilized and subjected to gel filtration using Sephadex G-100. The various fractions thus obtained were monitored at 280 nm and the pressor activity was re-estimated. It was observed that most of the pressor activity of the amniotic fluid of the toxaemic patients was capable of causing contraction of the rat colon as well as a significant rise in the systolic blood pressure of the intact rat. Furthermore, this activity was found to be heat-labile and was completely blocked by cinnarizine. Fractionation of the amniotic fluid showing vasopressor activity by gel filtration further substantiated the findings reported above. On the basis of these results it was concluded that the pressor activity of the amniotic fluid was due to the presence of an angiotensin II-like substance. Its concentration was found to be higher in the toxaemic group than in normotensive subjects.

摘要

在46例初产妇妊娠晚期评估了羊水的升压活性。受试者包括20例正常孕妇和26例妊娠中毒症患者。为了鉴定羊水的升压活性,对完整大鼠进行血压测量,并在体外测定大鼠升结肠标本的平滑肌收缩。将显示升压活性的羊水样本冻干,并用葡聚糖G - 100进行凝胶过滤。对由此获得的各种馏分在280 nm处进行监测,并重新评估其升压活性。观察到,妊娠中毒症患者羊水中的大部分升压活性能够引起大鼠结肠收缩以及完整大鼠收缩压显著升高。此外,发现这种活性对热不稳定,并被桂利嗪完全阻断。通过凝胶过滤对显示升压活性的羊水进行分级分离进一步证实了上述发现。基于这些结果得出结论,羊水的升压活性归因于一种类似血管紧张素II的物质的存在。发现其浓度在妊娠中毒症组中高于血压正常的受试者。

相似文献

1
Identification of vasopressor constituents of amniotic fluid in pregnancy toxaemia.妊娠毒血症中羊水升压成分的鉴定
Ric Clin Lab. 1979 Jan-Mar;9(1):25-33. doi: 10.1007/BF02905024.
2
Amniotic fluid retinol concentrations in late pregnancy.妊娠晚期羊水视黄醇浓度
Biol Neonate. 1986;49(2):81-4. doi: 10.1159/000242514.
3
Decreased levels of amniotic fluid oxytocinase activity in preeclampsia.子痫前期患者羊水中催产素酶活性水平降低。
Gynecol Obstet Invest. 1993;35(3):166-8. doi: 10.1159/000292691.
4
Total and free cortisol in amniotic fluid during late pregnancy.妊娠晚期羊水总皮质醇和游离皮质醇
Br J Obstet Gynaecol. 1978 Jun;85(6):446-50. doi: 10.1111/j.1471-0528.1978.tb14912.x.
5
PRESSOR POLYPEPTIDES IN AMNIOTIC FLUID OF NORMAL AND TOXEMIC PREGNANCY.正常妊娠和妊娠中毒症孕妇羊水内的升压多肽
Obstet Gynecol. 1964 Dec;24:914-7.
6
Corticotrophin releasing hormone levels in human plasma and amniotic fluid during gestation.妊娠期人血浆和羊水促肾上腺皮质激素释放激素水平
Clin Endocrinol (Oxf). 1994 Feb;40(2):257-62. doi: 10.1111/j.1365-2265.1994.tb02477.x.
7
Identification of a pressor polypeptide in human amniotic fluid.人羊水内一种升压多肽的鉴定
Am J Obstet Gynecol. 1971 Dec 15;111(8):1075-82. doi: 10.1016/0002-9378(71)90107-4.
8
[Manganese content of the amniotic fluid in physiological pregnancy, prolonged pregnancy and EPH gestosis].[生理妊娠、过期妊娠及妊娠高血压综合征时羊水的锰含量]
Ginekol Pol. 1983 Mar;54(3):179-81.
9
Prostacyclin-like, and kallikrein activity of amniotic fluid in pre-eclampsia.先兆子痫患者羊水的前列环素样物质及激肽释放酶活性
Br J Obstet Gynaecol. 1981 Dec;88(12):1217-22. doi: 10.1111/j.1471-0528.1981.tb01200.x.
10
[Glucose level in the amniotic fluid in pregnancy complicated by EPH-gestosis and diabetes].[妊娠合并妊娠高血压综合征和糖尿病时羊水葡萄糖水平]
Wiad Lek. 1982 Dec 15;35(23-24):1529-33.